PTC Misses Phase III In Friedrich Ataxia, But Isn’t Giving Up

Company Ends Gene Therapy R&D, Cuts Headcount

 
• By Joseph Haas
  
PTC
PTC maintains hopes in FA, exits gene therapy R&D • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business